The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme - New challenges for public health

Journal of Infection

Volumn 71, Issue 6, 2015, Pages 611-614

  Ladhani, Shamez N ^a   Campbell, Helen ^a   Parikh, Sydel R ^a   Saliba, Vanessa ^a   Borrow, Ray ^b   Ramsay, Mary ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Infant immunisation; Meningococcal B vaccine; Paracetamol; Post vaccination fever

Indexed keywords

MENINGOCOCCUS VACCINE; PARACETAMOL; 4CMENB VACCINE;

BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD HEALTH CARE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DRUG FEVER; DRUG LEGISLATION; DRUG TREATMENT FAILURE; EPIDEMIC; HUMAN; IMMUNIZATION; INFANT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MENINGOCOCCOSIS; MORBIDITY; MORTALITY; NATIONAL HEALTH SERVICE; NEISSERIA MENINGITIDIS; NONHUMAN; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PREVENTIVE MEDICINE; PROTOCOL COMPLIANCE; PUBLIC HEALTH SERVICE; REVIEW; RISK REDUCTION; UNITED KINGDOM; FEMALE; FEVER; GREAT BRITAIN; IMMUNOLOGY; MALE; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; STANDARDS; VACCINATION;

FEMALE; FEVER; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NATIONAL HEALTH PROGRAMS; NEISSERIA MENINGITIDIS, SEROGROUP B; PUBLIC HEALTH; VACCINATION;

EID: 84947619054     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.09.035     Document Type: Review

References (12)

1. Halperin S.A., Bettinger J.A., Greenwood B., Harrison L.H., Jelfs J., Ladhani S.N., et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine 2012, 30(Suppl. 2):B26-B36.
2. Ladhani S.N., Beebeejaun K., Lucidarme J., Campbell H., Gray S., Kaczmarski E., et al. Increase in endemic Neisseria meningitidis capsular group W ST-11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis 2015 Feb 15, 60(4):578-585.
3. Tan L.K., Carlone G.M., Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med 2010, 362:1511-1520.
4. Vogel U., Taha M.K., Vazquez J.A., Findlow J., Claus H., Stefanelli P., et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 2013, 13:416-425.
5. Frosi G., Biolchi A., Sapio M.L., Rigat F., Gilchrist S., Lucidarme J., et al. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. Vaccine 2013, 31:4968-4974.
6. Christensen H., May M., Bowen L., Hickman M., Trotter C.L. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:853-861.
7. Read R.C., Baxter D., Chadwick D.R., Faust S.N., Finn A., Gordon S.B., et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet 2014, 384:2123-2131.
8. Gossger N., Snape M.D., Yu L.M., Finn A., Bona G., Esposito S., et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 2012, 307:573-582.
9. Vesikari T., Esposito S., Prymula R., Ypma E., Kohl I., Toneatto D., et al. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 2013, 381:825-835.
10. Prymula R., Esposito S., Zuccotti G.V., Xie F., Toneatto D., Kohl I., et al. A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I). Hum Vaccin Immunother 2014, 10:1993-2004.
11. Prymula R., Siegrist C.A., Chlibek R., Zemlickova H., Vackova M., Smetana J., et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009, 374:1339-1350.
12. Das R.R., Panigrahi I., Naik S.S. The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review. PLoS One 2014, 9:e106629.